Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines

Business

Deals
Earnings
Manufacturing

Policy & Regulation

Regulatory Landscape
Drug Pricing
IP & Litigation

Tools & Trackers

What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings

Conference Coverage

Partner Insights

Generics Bulletin Perspectives

Exploring market-shifting topics for the off-patent sector.

Generics Bulletin

Medtech Insight

Sandoz And Polpharma Strike Global Deal For Natalizumab

Sep 04 2019

• By David Wallace

polpharma — Polpharma has licensed natalizumab rights to Sandoz • Source: Shutterstock

Related Content

Sandoz Forms Insulin Biosimilars Deal With Gan & Lee

Dec 19 2018

Polpharma Group expanding its capacity for biologicals

Nov 30 2018

Sandoz Fills Pipeline Gap With EirGenix Trastuzumab Deal

May 02 2019

Related Companies

Polpharma SA

Biogen, Inc.

Novartis AG

Additional Topics

International Deals Biosimilars BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window